OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel D2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment
Radomír Jůza, Iveta Vojtěchová, Kristýna Štefková, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114193-114193
Closed Access | Times Cited: 8
Radomír Jůza, Iveta Vojtěchová, Kristýna Štefková, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114193-114193
Closed Access | Times Cited: 8
Showing 8 citing articles:
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Dopaminergic and glutamatergic models of psychosis show differential sensitivity to aripiprazole and a novel experimental compound modulating D2/5-HT receptor activity
Iveta Vojtěchová, Klara Tuckova, Radomír Jůza, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 127, pp. 110819-110819
Closed Access | Times Cited: 4
Iveta Vojtěchová, Klara Tuckova, Radomír Jůza, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 127, pp. 110819-110819
Closed Access | Times Cited: 4
Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia
Zijin Feng, Zhijing Hu, Lei Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Zijin Feng, Zhijing Hu, Lei Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Identification of Potential Aldose Reductase Inhibitors Using Convolutional Neural Network-Based in Silico Screening
Kushagra Kashyap, Pinaki Prasad Mahapatra, Shakil Ahmed, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 20, pp. 6261-6282
Closed Access | Times Cited: 3
Kushagra Kashyap, Pinaki Prasad Mahapatra, Shakil Ahmed, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 20, pp. 6261-6282
Closed Access | Times Cited: 3
2-(((2,4-Dichlorophenyl)imino)methyl)-3,4-difluorophenol: X-ray, DFT, MEP, HOMO-LUMO, NLO, Hirshfeld Surfaces, ADMET Profiling, Target Identification, Antipsychotic Activity Against Dopamine D2 and Serotonin 5-HT2A Receptors
Songül Şahin
GAZI UNIVERSITY JOURNAL OF SCIENCE (2023) Vol. 37, Iss. 1, pp. 90-117
Open Access | Times Cited: 2
Songül Şahin
GAZI UNIVERSITY JOURNAL OF SCIENCE (2023) Vol. 37, Iss. 1, pp. 90-117
Open Access | Times Cited: 2
The Polypharmacology of Cariprazine and its Implications to Clinical Indications
Attila Egyed, Dóra Kiss, György M. Keserü
(2024), pp. 385-404
Closed Access
Attila Egyed, Dóra Kiss, György M. Keserü
(2024), pp. 385-404
Closed Access
Predictors of Serotonin Syndrome in Acute Poisoning with 5-Hydroxytryptamine Modulators
Asmaa Fady Sharif, Mubarak Nasir M. Almulhim, Hadi Mohamed A. Almosabeh, et al.
Toxics (2024) Vol. 12, Iss. 8, pp. 550-550
Open Access
Asmaa Fady Sharif, Mubarak Nasir M. Almulhim, Hadi Mohamed A. Almosabeh, et al.
Toxics (2024) Vol. 12, Iss. 8, pp. 550-550
Open Access
Psychiatric Etiologies and Approaches in Altered Mental Status Presentations: Insights from Consultation Liaison Psychiatry
Brandon Hamm, Lisa Rosenthal
Seminars in Neurology (2024)
Closed Access
Brandon Hamm, Lisa Rosenthal
Seminars in Neurology (2024)
Closed Access
